US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

ARMY HEALTH With CURCUMIN

Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Pharma-Natural Inc. D-1494-2019
Class II · Moderate risk Terminated

AbeeMed cream

Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Pharma-Natural Inc. D-1493-2019
Class II · Moderate risk Terminated

Oliver's Harvest CBD+Capsaicin 0.2% Pain Relief

Reason CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Pharma-Natural Inc. NDC 63788-120-04 D-1492-2019
Class II · Moderate risk Terminated

Losartan Potassium and Hydrochlorothiazide Tablets

Reason CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Macleods Pharma Usa Inc NDC 33342-051-10 D-1460-2019
Class II · Moderate risk Terminated

Losartan Potassium and Hydrochlorothiazide Tablets

Reason CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Macleods Pharma Usa Inc NDC 33342-050-10 D-1459-2019
Class II · Moderate risk Terminated

Losartan Potassium Tablets 50 mg 1000 Tablets

Reason CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Macleods Pharma Usa Inc NDC 33342-045-44 D-1458-2019
Class II · Moderate risk Terminated

Losartan Potassium Tablets

Reason CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Macleods Pharma Usa Inc NDC 33342-045-10 D-1457-2019
Class II · Moderate risk Terminated

Vitamin B Complex 100

Reason Lack of Assurance of Sterility

RXQ Compounding LLC D-1717-2019
Class II · Moderate risk Terminated

Vitamin B Complex 100

Reason Lack of Assurance of Sterility

RXQ Compounding LLC NDC 70731-0976-30 D-1716-2019
Class II · Moderate risk Terminated

Turbo Drops

Reason Lack of Assurance of Sterility

RXQ Compounding LLC NDC 70731-0205-05 D-1715-2019
Class II · Moderate risk Terminated

Turbo Drops

Reason Lack of Assurance of Sterility

RXQ Compounding LLC NDC 70731-0206-05 D-1714-2019
Class II · Moderate risk Terminated

Turbo Drops

Reason Lack of Assurance of Sterility

RXQ Compounding LLC NDC 70731-0192-81 D-1713-2019
Class II · Moderate risk Terminated

Turbo Caine 2.5

Reason Lack of Assurance of Sterility

RXQ Compounding LLC NDC 70731-0193-81 D-1712-2019
Class II · Moderate risk Terminated

Travasol 10%

Reason Lack of Assurance of Sterility

RXQ Compounding LLC NDC 70731-0151-50 D-1711-2019
Class II · Moderate risk Terminated

Thiamine HCL 100mg/Ml

Reason Lack of Assurance of Sterility

RXQ Compounding LLC NDC 70731-0950-10 D-1710-2019
Class II · Moderate risk Terminated

Taurine 50 Mg/Ml

Reason Lack of Assurance of Sterility

RXQ Compounding LLC NDC 70731-0958-30 D-1709-2019
Class II · Moderate risk Terminated

Sod-Phos

Reason Lack of Assurance of Sterility

RXQ Compounding LLC D-1706-2019
Class II · Moderate risk Terminated

Sodium Bicarbonate 8.4%

Reason Lack of Assurance of Sterility

RXQ Compounding LLC D-1704-2019
Class II · Moderate risk Terminated

Rxq Cain

Reason Lack of Assurance of Sterility

RXQ Compounding LLC D-1703-2019